1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Tuberculosis Vaccine Treatment Consumption 2016-2026 2.1.2 Tuberculosis Vaccine Treatment Consumption CAGR by Region 2.2 Tuberculosis Vaccine Treatment Segment by Type 2.2.1 Immune Vaccine 2.2.2 Therapy Vaccine 2.3 Tuberculosis Vaccine Treatment Sales by Type 2.3.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021) 2.3.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Type (2016-2021) 2.3.3 Global Tuberculosis Vaccine Treatment Sale Price by Type (2016-2021) 2.4 Tuberculosis Vaccine Treatment Segment by Application 2.4.1 Self-Procurement 2.4.2 UNICEF 2.4.3 Other 2.5 Tuberculosis Vaccine Treatment Sales by Application 2.5.1 Global Tuberculosis Vaccine Treatment Sale Market Share by Application (2016-2021) 2.5.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Application (2016-2021) 2.5.3 Global Tuberculosis Vaccine Treatment Sale Price by Application (2016-2021) 3 Global Tuberculosis Vaccine Treatment by Company 3.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Company 3.1.1 Global Tuberculosis Vaccine Treatment Sales by Company (2019-2021) 3.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Company (2019-2021) 3.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Company 3.2.1 Global Tuberculosis Vaccine Treatment Revenue by Company (2019-2021) 3.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Company (2019-2021) 3.3 Global Tuberculosis Vaccine Treatment Sale Price by Company 3.4 Global Manufacturers Tuberculosis Vaccine Treatment Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Tuberculosis Vaccine Treatment Product Location Distribution 3.4.2 Players Tuberculosis Vaccine Treatment Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 Tuberculosis Vaccine Treatment by Region 4.1 Global Tuberculosis Vaccine Treatment by Region 4.1.1 Global Tuberculosis Vaccine Treatment Sales by Region 4.1.2 Global Tuberculosis Vaccine Treatment Revenue by Region 4.2 Americas Tuberculosis Vaccine Treatment Sales Growth 4.3 APAC Tuberculosis Vaccine Treatment Sales Growth 4.4 Europe Tuberculosis Vaccine Treatment Sales Growth 4.5 Middle East & Africa Tuberculosis Vaccine Treatment Sales Growth 5 Americas 5.1 Americas Tuberculosis Vaccine Treatment Sales by Country 5.1.1 Americas Tuberculosis Vaccine Treatment Sales by Country (2016-2021) 5.1.2 Americas Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) 5.2 Americas Tuberculosis Vaccine Treatment Sales by Type 5.3 Americas Tuberculosis Vaccine Treatment Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Tuberculosis Vaccine Treatment Sales by Region 6.1.1 APAC Tuberculosis Vaccine Treatment Sales by Region (2016-2021) 6.1.2 APAC Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) 6.2 APAC Tuberculosis Vaccine Treatment Sales by Type 6.3 APAC Tuberculosis Vaccine Treatment Sales by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Tuberculosis Vaccine Treatment by Country 7.1.1 Europe Tuberculosis Vaccine Treatment Sales by Country (2016-2021) 7.1.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) 7.2 Europe Tuberculosis Vaccine Treatment Sales by Type 7.3 Europe Tuberculosis Vaccine Treatment Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Tuberculosis Vaccine Treatment by Country 8.1.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2021) 8.1.2 Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) 8.2 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type 8.3 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Tuberculosis Vaccine Treatment Distributors 10.3 Tuberculosis Vaccine Treatment Customer 11 Global Tuberculosis Vaccine Treatment Market Forecast 11.1 Global Tuberculosis Vaccine Treatment Forecast by Region 11.1.1 Global Tuberculosis Vaccine Treatment Forecast by Regions (2021-2026) 11.2.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Tuberculosis Vaccine Treatment Forecast by Type 11.7 Global Tuberculosis Vaccine Treatment Forecast by Application 12 Key Players Analysis 12.1 Merck 12.1.1 Merck Company Information 12.1.2 Merck Tuberculosis Vaccine Treatment Product Offered 12.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 Merck Main Business Overview 12.1.5 Merck Latest Developments 12.2 Japan BCG Lab 12.2.1 Japan BCG Lab Company Information 12.2.2 Japan BCG Lab Tuberculosis Vaccine Treatment Product Offered 12.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 Japan BCG Lab Main Business Overview 12.2.5 Japan BCG Lab Latest Developments 12.3 Serum Institute of India 12.3.1 Serum Institute of India Company Information 12.3.2 Serum Institute of India Tuberculosis Vaccine Treatment Product Offered 12.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 Serum Institute of India Main Business Overview 12.3.5 Serum Institute of India Latest Developments 12.4 AJ Vaccines 12.4.1 AJ Vaccines Company Information 12.4.2 AJ Vaccines Tuberculosis Vaccine Treatment Product Offered 12.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 AJ Vaccines Main Business Overview 12.4.5 AJ Vaccines Latest Developments 12.5 BioFarma 12.5.1 BioFarma Company Information 12.5.2 BioFarma Tuberculosis Vaccine Treatment Product Offered 12.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 BioFarma Main Business Overview 12.5.5 BioFarma Latest Developments 12.6 GreenSignal Bio Pharma 12.6.1 GreenSignal Bio Pharma Company Information 12.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Offered 12.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.6.4 GreenSignal Bio Pharma Main Business Overview 12.6.5 GreenSignal Bio Pharma Latest Developments 12.7 China National Biotec 12.7.1 China National Biotec Company Information 12.7.2 China National Biotec Tuberculosis Vaccine Treatment Product Offered 12.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.7.4 China National Biotec Main Business Overview 12.7.5 China National Biotec Latest Developments 12.8 Biomed Lublin 12.8.1 Biomed Lublin Company Information 12.8.2 Biomed Lublin Tuberculosis Vaccine Treatment Product Offered 12.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.8.4 Biomed Lublin Main Business Overview 12.8.5 Biomed Lublin Latest Developments 12.9 Taj Pharmaceuticals 12.9.1 Taj Pharmaceuticals Company Information 12.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Offered 12.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.9.4 Taj Pharmaceuticals Main Business Overview 12.9.5 Taj Pharmaceuticals Latest Developments 12.10 Ataulpho de Paiva 12.10.1 Ataulpho de Paiva Company Information 12.10.2 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Offered 12.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.10.4 Ataulpho de Paiva Main Business Overview 12.10.5 Ataulpho de Paiva Latest Developments 12.11 IVAC 12.11.1 IVAC Company Information 12.11.2 IVAC Tuberculosis Vaccine Treatment Product Offered 12.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.11.4 IVAC Main Business Overview 12.11.5 IVAC Latest Developments 12.12 Queen Saovabha Mem. Inst 12.12.1 Queen Saovabha Mem. Inst Company Information 12.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Offered 12.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.12.4 Queen Saovabha Mem. Inst Main Business Overview 12.12.5 Queen Saovabha Mem. Inst Latest Developments 12.13 Microgen 12.13.1 Microgen Company Information 12.13.2 Microgen Tuberculosis Vaccine Treatment Product Offered 12.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021) 12.13.4 Microgen Main Business Overview 12.13.5 Microgen Latest Developments 13 Research Findings and Conclusion

List of Tables Table 1. Tuberculosis Vaccine Treatment Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Immune Vaccine Table 3. Major Players of Therapy Vaccine Table 4. Global Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 5. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021) Table 6. Global Tuberculosis Vaccine Treatment Revenue by Type (2016-2021) & ($ million) Table 7. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2021) Table 8. Global Tuberculosis Vaccine Treatment Sale Price by Type (2016-2021) Table 9. Global Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 10. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021) Table 11. Global Tuberculosis Vaccine Treatment Value by Application (2016-2021) Table 12. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2021) Table 13. Global Tuberculosis Vaccine Treatment Sale Price by Application (2016-2021) Table 14. Global Tuberculosis Vaccine Treatment Sales by Company (2019-2021) & (K Dose) Table 15. Global Tuberculosis Vaccine Treatment Sales Market Share by Company (2019-2021) Table 16. Global Tuberculosis Vaccine Treatment Revenue by Company (2019-2021) ($ Millions) Table 17. Global Tuberculosis Vaccine Treatment Revenue Market Share by Company (2019-2021) Table 18. Global Tuberculosis Vaccine Treatment Sale Price by Company (2019-2021) Table 19. Key Manufacturers Tuberculosis Vaccine Treatment Producing Area Distribution and Sales Area Table 20. Players Tuberculosis Vaccine Treatment Products Offered Table 21. Tuberculosis Vaccine Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Tuberculosis Vaccine Treatment Sales by Region (2016-2021) (K Dose) Table 25. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021) Table 26. Global Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2021) Table 28. Americas Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose) Table 29. Americas Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021) Table 30. Americas Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021) Table 32. Americas Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 33. Americas Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021) Table 34. Americas Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 35. Americas Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021) Table 36. APAC Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose) Table 37. APAC Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021) Table 38. APAC Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2021) Table 40. APAC Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 41. APAC Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021) Table 42. APAC Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 43. APAC Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021) Table 44. Europe Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose) Table 45. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021) Table 46. Europe Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021) Table 48. Europe Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 49. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021) Table 50. Europe Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 51. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose) Table 53. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 57. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 59. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Tuberculosis Vaccine Treatment Table 61. Key Application and Potential Industries of Tuberculosis Vaccine Treatment Table 62. Key Challenges of Tuberculosis Vaccine Treatment Table 63. Key Trends of Tuberculosis Vaccine Treatment Table 64. Tuberculosis Vaccine Treatment Distributors List Table 65. Tuberculosis Vaccine Treatment Customer List Table 66. Global Tuberculosis Vaccine Treatment Sales Forecast by Region (2021-2026) & (K Dose) Table 67. Global Tuberculosis Vaccine Treatment Consumption Market Forecast by Region Table 68. Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Tuberculosis Vaccine Treatment Sales Forecast by Country (2021-2026) & (K Dose) Table 71. Americas Tuberculosis Vaccine Treatment Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Tuberculosis Vaccine Treatment Sales Forecast by Region (2021-2026) & (K Dose) Table 73. APAC Tuberculosis Vaccine Treatment Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Tuberculosis Vaccine Treatment Sales Forecast by Country (2021-2026) & (K Dose) Table 75. Europe Tuberculosis Vaccine Treatment Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Tuberculosis Vaccine Treatment Sales Forecast by Country (2021-2026) & (K Dose) Table 77. Middle East & Africa Tuberculosis Vaccine Treatment Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Tuberculosis Vaccine Treatment Sales Forecast by Type (2021-2026) & (K Dose) Table 79. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Type (2021-2026) Table 80. Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Tuberculosis Vaccine Treatment Sales Forecast by Application (2021-2026) & (K Dose) Table 83. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Application (2021-2026) Table 84. Global Tuberculosis Vaccine Treatment Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Application (2021-2026) Table 86. Merck Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 87. Merck Tuberculosis Vaccine Treatment Product Offered Table 88. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 89. Merck Main Business Table 90. Merck Latest Developments Table 91. Japan BCG Lab Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 92. Japan BCG Lab Tuberculosis Vaccine Treatment Product Offered Table 93. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 94. Japan BCG Lab Main Business Table 95. Japan BCG Lab Latest Developments Table 96. Serum Institute of India Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 97. Serum Institute of India Tuberculosis Vaccine Treatment Product Offered Table 98. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 99. Serum Institute of India Main Business Table 100. Serum Institute of India Latest Developments Table 101. AJ Vaccines Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 102. AJ Vaccines Tuberculosis Vaccine Treatment Product Offered Table 103. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 104. AJ Vaccines Main Business Table 105. AJ Vaccines Latest Developments Table 106. BioFarma Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 107. BioFarma Tuberculosis Vaccine Treatment Product Offered Table 108. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 109. BioFarma Main Business Table 110. BioFarma Latest Developments Table 111. GreenSignal Bio Pharma Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 112. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Offered Table 113. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 114. GreenSignal Bio Pharma Main Business Table 115. GreenSignal Bio Pharma Latest Developments Table 116. China National Biotec Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 117. China National Biotec Tuberculosis Vaccine Treatment Product Offered Table 118. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 119. China National Biotec Main Business Table 120. China National Biotec Latest Developments Table 121. Biomed Lublin Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 122. Biomed Lublin Tuberculosis Vaccine Treatment Product Offered Table 123. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 124. Biomed Lublin Main Business Table 125. Biomed Lublin Latest Developments Table 126. Taj Pharmaceuticals Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 127. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Offered Table 128. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 129. Taj Pharmaceuticals Main Business Table 130. Taj Pharmaceuticals Latest Developments Table 131. Ataulpho de Paiva Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 132. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Offered Table 133. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 134. Ataulpho de Paiva Main Business Table 135. Ataulpho de Paiva Latest Developments Table 136. IVAC Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 137. IVAC Tuberculosis Vaccine Treatment Product Offered Table 138. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 139. IVAC Main Business Table 140. IVAC Latest Developments Table 141. Queen Saovabha Mem. Inst Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 142. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Offered Table 143. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 144. Queen Saovabha Mem. Inst Main Business Table 145. Queen Saovabha Mem. Inst Latest Developments Table 146. Microgen Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors Table 147. Microgen Tuberculosis Vaccine Treatment Product Offered Table 148. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E) Table 149. Microgen Main Business Table 150. Microgen Latest Developments List of Figures Figure 1. Picture of Tuberculosis Vaccine Treatment Figure 2. Tuberculosis Vaccine Treatment Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Tuberculosis Vaccine Treatment Sales Growth Rate 2016-2026 (K Dose) Figure 7. Global Tuberculosis Vaccine Treatment Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Tuberculosis Vaccine Treatment Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Immune Vaccine Figure 10. Product Picture of Therapy Vaccine Figure 11. Global Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020 Figure 12. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2021) Figure 13. Tuberculosis Vaccine Treatment Consumed in Self-Procurement Figure 14. Global Tuberculosis Vaccine Treatment Market: Self-Procurement (2016-2021) & (K Dose) Figure 15. Tuberculosis Vaccine Treatment Consumed in UNICEF Figure 16. Global Tuberculosis Vaccine Treatment Market: UNICEF (2016-2021) & (K Dose) Figure 17. Tuberculosis Vaccine Treatment Consumed in Other Figure 18. Global Tuberculosis Vaccine Treatment Market: Other (2016-2021) & (K Dose) Figure 19. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021) Figure 20. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application in 2020 Figure 21. Tuberculosis Vaccine Treatment Revenue Market by Company in 2020 ($ Million) Figure 22. Global Tuberculosis Vaccine Treatment Revenue Market Share by Company in 2020 Figure 23. Global Tuberculosis Vaccine Treatment Sales Market Share by Regions (2016-2021) Figure 24. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region in 2020 Figure 25. Americas Tuberculosis Vaccine Treatment Sales 2016-2021 (K Dose) Figure 26. Americas Tuberculosis Vaccine Treatment Revenue 2016-2021 ($ Millions) Figure 27. APAC Tuberculosis Vaccine Treatment Sales 2016-2021 (K Dose) Figure 28. APAC Tuberculosis Vaccine Treatment Revenue 2016-2021 ($ Millions) Figure 29. Europe Tuberculosis Vaccine Treatment Sales 2016-2021 (K Dose) Figure 30. Europe Tuberculosis Vaccine Treatment Revenue 2016-2021 ($ Millions) Figure 31. Middle East & Africa Tuberculosis Vaccine Treatment Sales 2016-2021 (K Dose) Figure 32. Middle East & Africa Tuberculosis Vaccine Treatment Revenue 2016-2021 ($ Millions) Figure 33. Americas Tuberculosis Vaccine Treatment Sales Market Share by Country in 2020 Figure 34. Americas Tuberculosis Vaccine Treatment Revenue Market Share by Country in 2020 Figure 35. Americas Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020 Figure 36. Americas Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020 Figure 37. United States Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 38. Canada Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 39. Mexico Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 40. Brazil Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 41. APAC Tuberculosis Vaccine Treatment Sales Market Share by Region in 2020 Figure 42. APAC Tuberculosis Vaccine Treatment Revenue Market Share by Regions in 2020 Figure 43. APAC Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020 Figure 44. APAC Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020 Figure 45. China Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 46. Japan Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 47. Korea Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 48. Southeast Asia Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 49. India Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 50. Australia Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 51. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country in 2020 Figure 52. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country in 2020 Figure 53. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020 Figure 54. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020 Figure 55. Germany Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 56. France Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 57. UK Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 58. Italy Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 59. Russia Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 60. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Country in 2020 Figure 61. Middle East & Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country in 2020 Figure 62. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020 Figure 63. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020 Figure 64. Egypt Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 65. South Africa Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 66. Israel Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 67. Turkey Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 68. GCC Country Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions) Figure 69. Channels of Distribution Figure 70. Distributors Profiles